Clinical Trials on Coronary Microvascular Disease

Total 377228 results

RenJi Hospital

Unknown

Hierarchical Treatment Based on Somatization Symptom Checklist

Syndrome X

China
Rio de Janeiro State University
Laboratory for Clinical and Experimental Research on Vascular Biology

Completed

Acute and Short-term Chronic Effects of Galvus (Vildagliptin) in Diabetes Type 2 Obese Women

1- Microvascular Function | 2-oxidative Stress | 3-inflammation

Brazil
Hemoteq AG

Completed

Comparison of Agent™ and SeQuent® Please Paclitaxel Coated Balloon Catheters in Coronary In-stent Restenosis (AGENT-ISR) (AGENT-ISR)

Coronary Artery Disease | Coronary Arteriosclerosis | Coronary Atherosclerosis | Coronary Restenosis

Germany, France
Samsung Medical Center

Recruiting

Relationship Between Coronary Microvascular Dysfunction and Improvement of Left Ventricular Systolic Function in Patients With Heart Failure With Reduced Ejection Fraction Caused by Non-ischemic Etiology (HFrEF-CMD)

Heart Failure | Microvascular Angina | Non-ischemic Cardiomyopathy

Korea, Republic of
Medical University of Silesia

Completed

PCI vs. CABG in UPLM-ISR (LM-DRAGON)

Left Main Coronary Artery Disease | Restenosis, Coronary | PTCA Left Main Artery Complications

Poland, Italy
Johns Hopkins University
Northwestern University

Completed

Coronary Atherosclerosis Evaluation by Arterial Wall Magnetic Resonance Imaging (MRI)

Coronary Artery Disease | Coronary Arteriosclerosis | Coronary Atherosclerosis | Atherosclerosis, Coronary | Arteriosclerosis, Coronary

United States
Abbott Medical Devices

Completed

XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA Long Term Follow-up Cohort) (XVU-LTF)

Myocardial Ischemia | Coronary Artery Disease | Coronary Disease | Coronary Restenosis | Chronic Coronary Occlusion | Vascular Disease | Coronary Artery Stenosis

United States
Fondazione Evidence per Attività e Ricerche Cardiovascolari...

Not yet recruiting

SPAGO: Sirolimus Paclitaxel Angiographic Gain Objective (SPAGO)

Coronary Artery Disease | Percutaneous Coronary Intervention | Coronary Artery Lesion | Stenosis Coronary
CID - Carbostent & Implantable Devices

Completed

COMPETE: A Clinical Evaluation of Chrono Carbostent Carbofilm™ Coated Stent (COMPETE)

Myocardial Ischemia | Coronary Stenosis | Coronary Artery Diseases | Coronary Atherosclerotic Disease | Coronary Occlusive Diseases

Italy
Abbott Medical Devices

Completed

EXecutive RCT: Evaluating XIENCE V® in a Multi Vessel Disease (EXecutive)

Coronary Artery Disease | Coronary Disease | Coronary Artery Stenosis | Coronary Artery Restenosis

Italy
Abbott Medical Devices

Completed

EXecutive Registry: Evaluating XIENCE V® in a Multi Vessel Disease (EXecutive)

Coronary Artery Disease | Coronary Disease | Coronary Artery Stenosis | Coronary Artery Restenosis

Italy
Fundación EPIC

Recruiting

ANGiographic Evaluation of Left Main Coronary Artery INtErvention (ANGELINE)

Coronary Artery Disease | Coronary Disease | Coronary Occlusion | Left Main Coronary Artery Disease | Coronary Artery Stenosis

Spain
Abbott Medical Devices

Completed

EXCEL Clinical Trial (Universal Registry) (EXCEL)

Myocardial Ischemia | Coronary Artery Disease | Coronary Disease | Left Main Coronary Artery Disease | Stent Thrombosis | Coronary Restenosis | Chronic Coronary Occlusion | Vascular Disease | Coronary Artery Stenosis

United States
Samsung Medical Center

Unknown

Understanding of Chest Pain in Microvascular Disease Proved by Cardiac Magnetic Resonance Image (UMPIRE)

Microvascular Angina

Korea, Republic of
Samsung Medical Center

Completed

Determination of Target of Adequate Partial Neuromuscular Blockade for Electrophysiologic Monitoring During Microvascular Decompression Surgery

Neuromuscular Blockade | Hemifacial Spasm | Microvascular Decompression

Korea, Republic of
Abbott Medical Devices

Completed

EXCEL Clinical Trial (EXCEL)

Myocardial Ischemia | Coronary Artery Disease | Coronary Disease | Stent Thrombosis | Coronary Restenosis | Chronic Coronary Occlusion | Vascular Disease | Coronary Artery Stenosis | Unprotected Left Main Coronary Artery Disease

United States
Abbott Medical Devices

Completed

SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS)

Myocardial Ischemia | Coronary Artery Disease | Stent Thrombosis | Vascular Disease | Coronary Artery Stenosis | Stents | Total Coronary Occlusion | Coronary Artery Restenosis

United States
Fatebenefratelli and Ophthalmic Hospital

Completed

The All-comers Sirolimus-coated Balloon European Registry (EASTBOURNE)

Percutaneous Coronary Intervention | Angioplasty, Balloon, Coronary | Arteriosclerosis, Coronary | Coronary Angioplasty, Transluminal Balloon

Italy
Peking Union Medical College Hospital

Not yet recruiting

Disease Characteristics of IR-CAD: a Case-control Study

Coronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation Vascular

China
Eva Prescott

Completed

Glucagon-like Peptide-1 and Coronary Microvascular Dysfunction in Women With Angina Pectoris and no Coronary Stenosis (GAP)

Microvascular Angina

Denmark
Peking Union Medical College Hospital

Recruiting

Efficacy and Safety of Comprehensive Treatment in Patients With IR-CAD: a Self-controlled Cohort Study

Coronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation Vascular

China
Bispebjerg Hospital

Completed

Effect of Glucagon-like Peptide 1 (GLP-1) on Microvascular Myocardial Function in Patients With Type 2 Diabetes. (EGOFIP)

Type 2 Diabetes | Microvascular Dysfunction

Denmark
IGLESIAS Juan Fernando
University of Bern

Not yet recruiting

P2Y12 Inhibitor-based Single Antiplatelet Therapy After a Short DAPT vs. Conventional DAPT Following PCI With a Polymer-free Drug-coated Stent for Unprotected Left Main Coronary Artery Disease (ULTRA-LM) (ULTRA-LM)

Left Main Coronary Artery Stenosis

Switzerland
Barts & The London NHS Trust
Imperial College London; Brunel University

Not yet recruiting

Multisensor Array for the Localisation of Coronary Artery Stenosis (MALCAS) (MALCAS)

CORONARY ARTERY DISEASE
Centro de estudios en Cardiologia Intervencionista

Completed

Study of Oral Rapamycin Plus Bare Metal Stents vs Drug Eltuting Stents (ORAR III)

Coronary Heart Disease | Coronary Restenosis

Argentina
Johannes Gutenberg University Mainz

Recruiting

MICRO: a Registry Study in Patients With Microvascular Angina (MICRO)

Microvascular Disease

Germany
Deutsches Herzzentrum Muenchen

Completed

Efficacy Study of Rapamycin- vs. Zotarolimus-Eluting Stents to Reduce Coronary Restenosis (ISAR-TEST-5)

Coronary Heart Disease

Germany
University of Aarhus
Novartis; Danish Heart Foundation; Danish Cardiovascular Research Academy

Terminated

Effects of Intensive Long-Term Vasodilation in Hypertensive Patients With Microvascular Angina Pectoris

Hypertension | Microvascular Angina

Denmark
Region Örebro County

Recruiting

CT in Calcified Coronary Arteries With Photon Counting Detector (CCT-PCD-1)

Coronary Stenosis | Calcific Coronary Arteriosclerosis

Sweden
China National Center for Cardiovascular Diseases

Unknown

Risk Factors of Intermediate Coronary Lesion Progression

Coronary Angiography | Coronary Atheroscleroses

China
Jesse Brown VA Medical Center

Unknown

SOLEMN Study - Synergy Optical Coherence Tomography in Left Main PCI (SOLEMN)

Percutaneous Coronary Intervention | Optical Coherence Tomography | In-stent Coronary Artery Restenosis

United States
Abbott Medical Devices

Completed

XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval, Single-Arm Study (XV CHINA SAS)

Myocardial Ischemia | Coronary Artery Disease | Coronary Disease | Stent Thrombosis | Coronary Restenosis | Chronic Coronary Occlusion | Vascular Disease | Coronary Artery Stenosis | Angioplasty

United States
Abbott Medical Devices

Completed

XIENCE V/PROMUS Everolimus-Eluting Stent System Post-marketing Surveillance Protocol for Japan

Myocardial Ischemia | Coronary Artery Disease | Coronary Disease | Stent Thrombosis | Coronary Restenosis | Chronic Coronary Occlusion | Vascular Disease | Coronary Artery Stenosis | Angina

Japan
Medstar Health Research Institute

Withdrawn

REWARDS- In-stent Restenosis

In-Stent Coronary Artery Restenosis

United States
Medstar Health Research Institute

Unknown

Intra-stent Tissue Evaluation Within BMS and DES > 3 Years Since Implantation

In-stent Coronary Artery Restenosis

United States
Biotronik AG

Completed

Paclitaxel Releasing Balloon in Patients Presenting With In-Stent Restenosis (PEPPER)

In-stent Coronary Artery Restenosis

Germany
National Institutes of Health Clinical Center (CC)
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Gadofosveset Trisodium for Heart Imaging Studies

Coronary Arteriosclerosis | Coronary Artery Disease (CAD) | Obstructive Coronary Artery Disease

United States
National Heart Centre Singapore

Unknown

Analysis of Coronary CT Angiography to Identify Patients With Significant Coronary Artery Stenosis (CTAAnalyzer)

Coronary Heart Disease

Singapore
Seung-Jung Park
CardioVascular Research Foundation, Korea

Recruiting

Evaluation of Effectiveness and Safety of Hybrid Coronary Revascularization (HCR registry)

Coronary Stenosis | Coronary Artery Bypass Grafting | Coronary Artery Disease Progression | Percutaneous Coronary Revascularization

Korea, Republic of
Rambam Health Care Campus

Completed

In-stent Restenosis in Patients With Patent Previous Bare Metal Stent

In-stent Coronary Artery Restenosis

Israel
Ospedale Santa Maria Goretti

Withdrawn

Prognostic Assessment of Different Pattern of Bifurcation Restenosis (LATINA)

In-stent Coronary Artery Restenosis

Italy
MINVASYS
European Cardiovascular Research Center

Completed

Safety and Efficacy Study of the DANUBIO Paclitaxel Eluting Balloon in In-Stent Restenosis Lesions (DEBREST) (DEBREST)

In-stent Coronary Artery Restenosis

France
Qilu Hospital of Shandong University

Recruiting

Microvascular Angina Intervention With Compound Danshen Dripping Pill (MAIDS) (MAIDS)

Microvascular Angina

China
Massachusetts General Hospital
Forest Laboratories

Completed

Study to Evaluate Effect of Nebivolol on Angina in Women With Microvascular Disease (NIRVANA)

Microvascular Angina

United States
China National Center for Cardiovascular Diseases

Recruiting

Functional Diagnostic Accuracy of Ultrasonic Flow Ratio in Assessment of Left Main Coronary Artery Stenosis (FUNCTION II)

Left Main Coronary Artery Disease

China
Second Xiangya Hospital of Central South University

Unknown

Effect of Ticagrelor on Adenosine-Induced Coronary Flow Reserve in Patients With Microvascular Angina

Microvascular Angina
Abbott Medical Devices
Bristol-Myers Squibb; Eli Lilly and Company; Daiichi Sankyo, Inc.; Baim Institute...

Completed

XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort (XVU-AV DAPT)

Myocardial Ischemia | Coronary Artery Disease | Coronary Disease | Chronic Total Occlusion of Coronary Artery | Coronary Restenosis | Vascular Disease | Coronary Artery Stenosis

United States
Clinica Mediterranea

Completed

The XLIMUS-DES in Very Complex Lesions

Chronic Total Occlusion of Coronary Artery | Coronary Atherosclerosis Due to Calcified Coronary Lesion

Italy
University of Turku
Finnish Foundation for Cardiovascular Research

Unknown

CRAGS (Coronary aRtery diseAse in younG adultS) (CRAGS)

Coronary Artery Disease | Percutaneous Coronary Intervention | Coronary Artery Bypass Grafting | Acute Coronary Syndromes | Young Patient

Finland, Italy, Iceland, Sweden
Johns Hopkins University
American Heart Association; Apple Inc.

Recruiting

Impact of a Corrie Cardiac Rehabilitation Program (mTECH-Rehab)

Myocardial Infarction | Myocardial Ischemia | Coronary Artery Disease | Valve Heart Disease | Coronary Artery Occlusion | Bypass Graft Occlusion | Coronary Artery Stenosis Stent

United States

Clinical Trials on Coronary Microvascular Disease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Costa Rica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations